Edition:
India

Energy

AOSL.BO
ADPE.BO
UNDR.BO

Libya's NOC says Schlumberger agrees to tech transfer to reopen wells

CAIRO, Dec 2 Libya's National Oil Corp (NOC) said on Wednesday its Chairman Mustafa Sanallah and Schlumberger Ltd Chief Executive Olivier Le Peuch agreed on technology transfer talks to help restart the country's oil wells and improve output.

5:26am IST

UPDATE 3-Xiaomi indicates shares priced at HK$23.70 - term sheet

HONG KONG, Dec 1 Chinese smartphone maker Xiaomi Corp is set to price its huge equity top-up placement at the lower end of the range, according to a term sheet seen by Reuters.

5:20am IST

U.S. refining industry trade group sets in-person spring 2021 meeting

NEW YORK, Dec 1 The American Fuel & Petrochemical Manufacturers, a top U.S. oil refining industry trade group, will hold its annual conference early next year in-person, one of the first to do so after the coronavirus pandemic sent conferences to virtual meetings.

5:14am IST

UPDATE 9-Oil slides as OPEC+ delays decision on output cuts

* U.S. crude stocks rose 4.1 million barrels last week -API (Adds API data, after-market trading in paragraph 3)

3:20am IST

U.S. CFTC issues record number of enforcement actions, as fines remain largely flat

WASHINGTON, Dec 1 The U.S. derivatives regulator issued a record 113 enforcement actions for corporate wrongdoing in 2020 - the most in the agency's history - the agency said on Tuesday, even as total monetary fines remained almost flat.

2:48am IST
BSE OIL & GAS +2.12%
BSE BANKEX +0.63%
BSE METALS +1.50%
BSE REALTY +3.49%
BSE AUTO +1.17%
BSE POWER +0.95%
BSE-CG +0.77%

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Photo

AstraZeneca partner sticks with two full dose regimen in COVID trials in India

PUNE Serum Institute of India, which has partnered with AstraZeneca to manufacture its COVID-19 vaccine, will continue to test a two full dose regimen of the shot despite it showing a lower success rate than a half and full dose regimen in pivotal trials, a top executive told Reuters.